Michelle D. Holmes, Dr.P.H., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Breast Neoplasms | 93 | 2024 | 21162 | 3.510 |
Why?
|
Aspirin | 8 | 2024 | 3135 | 1.810 |
Why?
|
Diet | 31 | 2022 | 8088 | 1.460 |
Why?
|
Nurses | 26 | 2024 | 2503 | 1.210 |
Why?
|
Postmenopause | 20 | 2024 | 2517 | 1.190 |
Why?
|
Dietary Fats | 13 | 2014 | 2001 | 1.150 |
Why?
|
Diet, Carbohydrate-Restricted | 2 | 2023 | 263 | 1.000 |
Why?
|
Dietary Fiber | 7 | 2020 | 767 | 0.930 |
Why?
|
Tea | 2 | 2021 | 289 | 0.910 |
Why?
|
Vegetables | 7 | 2021 | 1199 | 0.900 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 4 | 2024 | 2270 | 0.790 |
Why?
|
Feeding Behavior | 10 | 2021 | 3208 | 0.770 |
Why?
|
Coffee | 2 | 2021 | 594 | 0.750 |
Why?
|
Receptors, Estrogen | 11 | 2024 | 2251 | 0.740 |
Why?
|
Cognitive Dissonance | 1 | 2021 | 14 | 0.740 |
Why?
|
Fruit | 5 | 2020 | 1166 | 0.730 |
Why?
|
Chiropractic | 1 | 2021 | 39 | 0.720 |
Why?
|
Students, Health Occupations | 1 | 2021 | 30 | 0.720 |
Why?
|
Drinking Behavior | 1 | 2021 | 102 | 0.710 |
Why?
|
Life Style | 13 | 2024 | 3926 | 0.660 |
Why?
|
Africa South of the Sahara | 7 | 2021 | 751 | 0.590 |
Why?
|
Risk Factors | 73 | 2024 | 74881 | 0.590 |
Why?
|
Professional Role | 1 | 2021 | 314 | 0.590 |
Why?
|
Amino Acids, Essential | 1 | 2016 | 26 | 0.550 |
Why?
|
Acne Vulgaris | 3 | 2008 | 352 | 0.540 |
Why?
|
Accidents | 1 | 2017 | 164 | 0.540 |
Why?
|
Alcohol Drinking | 8 | 2021 | 4045 | 0.530 |
Why?
|
Papillomavirus Infections | 2 | 2018 | 1639 | 0.520 |
Why?
|
Milk | 3 | 2008 | 436 | 0.500 |
Why?
|
Fast Foods | 1 | 2018 | 220 | 0.500 |
Why?
|
Female | 127 | 2024 | 396520 | 0.500 |
Why?
|
Dietary Proteins | 6 | 2021 | 960 | 0.500 |
Why?
|
Middle Aged | 101 | 2024 | 223257 | 0.490 |
Why?
|
Survival Analysis | 17 | 2021 | 10100 | 0.480 |
Why?
|
Prospective Studies | 52 | 2024 | 54871 | 0.470 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2016 | 267 | 0.450 |
Why?
|
Adult | 89 | 2024 | 223307 | 0.430 |
Why?
|
Multivariate Analysis | 25 | 2016 | 12064 | 0.430 |
Why?
|
Dietary Carbohydrates | 5 | 2021 | 896 | 0.420 |
Why?
|
Diet Surveys | 5 | 2011 | 1159 | 0.410 |
Why?
|
Proportional Hazards Models | 20 | 2024 | 12534 | 0.410 |
Why?
|
Motor Activity | 4 | 2013 | 2711 | 0.400 |
Why?
|
Humans | 149 | 2024 | 766766 | 0.400 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2018 | 492 | 0.400 |
Why?
|
Papillomavirus Vaccines | 1 | 2018 | 497 | 0.390 |
Why?
|
Papillomaviridae | 1 | 2018 | 1139 | 0.380 |
Why?
|
Urban Population | 3 | 2016 | 2040 | 0.380 |
Why?
|
Follow-Up Studies | 24 | 2024 | 39309 | 0.370 |
Why?
|
Violence | 1 | 2017 | 931 | 0.370 |
Why?
|
Residence Characteristics | 2 | 2022 | 2116 | 0.360 |
Why?
|
Estrone | 1 | 2012 | 234 | 0.360 |
Why?
|
Off-Label Use | 1 | 2012 | 185 | 0.360 |
Why?
|
Gonadal Steroid Hormones | 4 | 2005 | 706 | 0.360 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 2 | 2002 | 416 | 0.350 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2013 | 1241 | 0.350 |
Why?
|
Drug Repositioning | 1 | 2012 | 246 | 0.350 |
Why?
|
Receptors, Progesterone | 7 | 2024 | 1159 | 0.350 |
Why?
|
Rural Population | 2 | 2021 | 2321 | 0.340 |
Why?
|
Estrogens | 2 | 2012 | 1528 | 0.340 |
Why?
|
United States | 38 | 2024 | 72951 | 0.340 |
Why?
|
Nutritional Status | 3 | 2021 | 1621 | 0.330 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2013 | 1514 | 0.330 |
Why?
|
Meat | 4 | 2010 | 588 | 0.320 |
Why?
|
Quality of Life | 7 | 2024 | 13476 | 0.310 |
Why?
|
Cyclooxygenase 2 | 1 | 2011 | 596 | 0.310 |
Why?
|
Sexual Behavior | 2 | 2018 | 2192 | 0.310 |
Why?
|
Cohort Studies | 26 | 2023 | 41710 | 0.300 |
Why?
|
Healthcare Disparities | 1 | 2024 | 3411 | 0.300 |
Why?
|
Anticarcinogenic Agents | 1 | 2010 | 251 | 0.300 |
Why?
|
Breast | 1 | 2017 | 1971 | 0.290 |
Why?
|
Carcinoma, Lobular | 1 | 2011 | 480 | 0.280 |
Why?
|
Attitude of Health Personnel | 1 | 2021 | 3927 | 0.270 |
Why?
|
Exercise | 11 | 2024 | 5945 | 0.270 |
Why?
|
Obesity | 7 | 2021 | 13090 | 0.270 |
Why?
|
Health Policy | 2 | 2018 | 2698 | 0.270 |
Why?
|
alpha-Tocopherol | 1 | 2007 | 127 | 0.270 |
Why?
|
Public Health | 2 | 2017 | 2681 | 0.260 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2011 | 1097 | 0.260 |
Why?
|
Physicians | 1 | 2024 | 4591 | 0.260 |
Why?
|
Weight Gain | 3 | 2021 | 2356 | 0.260 |
Why?
|
Vaccination | 1 | 2018 | 3434 | 0.260 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2024 | 3552 | 0.250 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2018 | 2039 | 0.250 |
Why?
|
Drug Residues | 1 | 2005 | 7 | 0.250 |
Why?
|
Physical Fitness | 1 | 2009 | 743 | 0.240 |
Why?
|
Flavonols | 1 | 2005 | 84 | 0.240 |
Why?
|
Wounds and Injuries | 1 | 2017 | 2513 | 0.240 |
Why?
|
Social Support | 4 | 2010 | 2191 | 0.230 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2002 | 1935 | 0.230 |
Why?
|
Carotenoids | 2 | 2007 | 620 | 0.230 |
Why?
|
Estradiol | 1 | 2012 | 1947 | 0.230 |
Why?
|
Social Class | 2 | 2022 | 2007 | 0.230 |
Why?
|
Dairy Products | 2 | 2005 | 490 | 0.230 |
Why?
|
Survivors | 5 | 2013 | 2379 | 0.220 |
Why?
|
Neoplasm Staging | 10 | 2021 | 11218 | 0.220 |
Why?
|
Prevalence | 11 | 2017 | 15835 | 0.220 |
Why?
|
Caffeine | 1 | 2008 | 702 | 0.220 |
Why?
|
Diabetes Mellitus, Type 2 | 7 | 2024 | 12245 | 0.210 |
Why?
|
Premenopause | 7 | 2024 | 1039 | 0.210 |
Why?
|
Aged | 43 | 2024 | 171343 | 0.210 |
Why?
|
Incidence | 16 | 2024 | 21525 | 0.210 |
Why?
|
Body Mass Index | 11 | 2016 | 13050 | 0.200 |
Why?
|
Complementary Therapies | 1 | 2006 | 486 | 0.200 |
Why?
|
Cause of Death | 6 | 2021 | 3716 | 0.190 |
Why?
|
Eggs | 1 | 2003 | 182 | 0.190 |
Why?
|
Neoplasms | 5 | 2024 | 22350 | 0.190 |
Why?
|
Metformin | 2 | 2024 | 908 | 0.190 |
Why?
|
Neoplasm Recurrence, Local | 7 | 2024 | 9404 | 0.180 |
Why?
|
Energy Intake | 7 | 2022 | 2142 | 0.180 |
Why?
|
Survival Rate | 6 | 2023 | 12825 | 0.180 |
Why?
|
Nutrition Assessment | 5 | 2021 | 739 | 0.170 |
Why?
|
New Zealand | 1 | 2021 | 360 | 0.170 |
Why?
|
Diet Therapy | 1 | 2021 | 149 | 0.170 |
Why?
|
Nutritive Value | 2 | 2021 | 351 | 0.170 |
Why?
|
Anthropometry | 2 | 2021 | 1336 | 0.170 |
Why?
|
Cross-Sectional Studies | 12 | 2021 | 26310 | 0.170 |
Why?
|
Hyperinsulinism | 1 | 2022 | 402 | 0.170 |
Why?
|
Fishes | 1 | 2003 | 607 | 0.170 |
Why?
|
Menopause | 3 | 2024 | 1657 | 0.160 |
Why?
|
Smoking | 9 | 2007 | 9077 | 0.160 |
Why?
|
Logistic Models | 5 | 2016 | 13278 | 0.160 |
Why?
|
Confidence Intervals | 6 | 2020 | 2921 | 0.160 |
Why?
|
Epilepsies, Partial | 2 | 2003 | 431 | 0.160 |
Why?
|
Carcinoma | 1 | 2010 | 2324 | 0.160 |
Why?
|
Pilot Projects | 3 | 2024 | 8728 | 0.160 |
Why?
|
Canada | 1 | 2024 | 2126 | 0.150 |
Why?
|
Vitamin A | 1 | 2021 | 611 | 0.150 |
Why?
|
Sweetening Agents | 1 | 2021 | 291 | 0.150 |
Why?
|
Disease-Free Survival | 3 | 2024 | 6850 | 0.150 |
Why?
|
Risk | 7 | 2010 | 9602 | 0.150 |
Why?
|
Hypertension | 4 | 2016 | 8616 | 0.150 |
Why?
|
Remission Induction | 1 | 2024 | 2413 | 0.150 |
Why?
|
Tanzania | 3 | 2016 | 1406 | 0.140 |
Why?
|
Odds Ratio | 7 | 2016 | 9661 | 0.140 |
Why?
|
Young Adult | 10 | 2024 | 59939 | 0.140 |
Why?
|
Overweight | 2 | 2020 | 2446 | 0.140 |
Why?
|
Uganda | 3 | 2016 | 1353 | 0.140 |
Why?
|
North America | 1 | 2021 | 1287 | 0.140 |
Why?
|
Australia | 1 | 2021 | 1263 | 0.140 |
Why?
|
Folic Acid | 3 | 2018 | 1337 | 0.140 |
Why?
|
Stress, Psychological | 2 | 2020 | 4527 | 0.140 |
Why?
|
Body Weight | 2 | 2005 | 4626 | 0.140 |
Why?
|
Nutrition Surveys | 4 | 2007 | 1737 | 0.140 |
Why?
|
Nigeria | 2 | 2016 | 781 | 0.130 |
Why?
|
Adolescent | 21 | 2022 | 88904 | 0.130 |
Why?
|
Neoplasm Metastasis | 2 | 2017 | 4891 | 0.130 |
Why?
|
Administration, Oral | 1 | 2024 | 4018 | 0.130 |
Why?
|
Beverages | 1 | 2021 | 819 | 0.120 |
Why?
|
Male | 28 | 2024 | 364142 | 0.120 |
Why?
|
Risk Assessment | 11 | 2016 | 24295 | 0.120 |
Why?
|
Uterine Cervical Diseases | 2 | 1993 | 75 | 0.120 |
Why?
|
Internationality | 1 | 2021 | 1006 | 0.120 |
Why?
|
Health Surveys | 5 | 2018 | 4055 | 0.120 |
Why?
|
Ki-67 Antigen | 1 | 2017 | 630 | 0.120 |
Why?
|
Urbanization | 1 | 2015 | 100 | 0.120 |
Why?
|
Leucine | 1 | 2016 | 547 | 0.120 |
Why?
|
Educational Status | 4 | 2017 | 2510 | 0.120 |
Why?
|
Behavior | 1 | 1998 | 538 | 0.120 |
Why?
|
Carbon | 1 | 2018 | 673 | 0.120 |
Why?
|
Regression Analysis | 6 | 2012 | 6329 | 0.120 |
Why?
|
Biomedical Research | 1 | 2010 | 3459 | 0.120 |
Why?
|
Eating | 1 | 2021 | 1539 | 0.120 |
Why?
|
Prognosis | 11 | 2022 | 29948 | 0.110 |
Why?
|
Time Factors | 9 | 2017 | 40149 | 0.110 |
Why?
|
Health Behavior | 2 | 2015 | 2649 | 0.110 |
Why?
|
South Africa | 2 | 2016 | 1875 | 0.110 |
Why?
|
Europe | 1 | 2021 | 3430 | 0.110 |
Why?
|
Vitamin D | 4 | 2012 | 3270 | 0.110 |
Why?
|
Fee-for-Service Plans | 1 | 2019 | 713 | 0.110 |
Why?
|
Income | 2 | 2020 | 1875 | 0.110 |
Why?
|
Prunus | 1 | 2013 | 12 | 0.110 |
Why?
|
Occupations | 1 | 2015 | 516 | 0.110 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2014 | 208 | 0.110 |
Why?
|
Dietary Supplements | 2 | 2018 | 3429 | 0.100 |
Why?
|
Prostatic Neoplasms | 2 | 2007 | 11094 | 0.100 |
Why?
|
Betaine | 2 | 2010 | 90 | 0.100 |
Why?
|
Massachusetts | 3 | 2018 | 8891 | 0.100 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2022 | 2881 | 0.100 |
Why?
|
Chlamydia Infections | 2 | 1993 | 365 | 0.100 |
Why?
|
Chlamydia trachomatis | 2 | 1993 | 239 | 0.100 |
Why?
|
Cattle | 3 | 2009 | 3815 | 0.100 |
Why?
|
Adipokines | 1 | 2014 | 308 | 0.100 |
Why?
|
Anemia | 1 | 2021 | 1514 | 0.100 |
Why?
|
Linear Models | 4 | 2014 | 5874 | 0.100 |
Why?
|
Caregivers | 1 | 2004 | 2303 | 0.100 |
Why?
|
Forecasting | 1 | 2021 | 2936 | 0.100 |
Why?
|
Epidemiologic Studies | 1 | 2015 | 677 | 0.100 |
Why?
|
Digoxin | 1 | 2012 | 246 | 0.100 |
Why?
|
Cardiovascular Diseases | 4 | 2015 | 15657 | 0.090 |
Why?
|
Electroencephalography | 5 | 2004 | 6282 | 0.090 |
Why?
|
Longitudinal Studies | 6 | 2021 | 14762 | 0.090 |
Why?
|
Hypoglycemic Agents | 1 | 2024 | 3108 | 0.090 |
Why?
|
Sweden | 1 | 2014 | 1382 | 0.090 |
Why?
|
Students | 2 | 2018 | 1741 | 0.090 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2004 | 4056 | 0.090 |
Why?
|
Choline | 2 | 2010 | 511 | 0.090 |
Why?
|
Antineoplastic Agents | 2 | 2011 | 13643 | 0.090 |
Why?
|
Neoplasms, Hormone-Dependent | 2 | 2011 | 409 | 0.090 |
Why?
|
Mass Screening | 2 | 2005 | 5454 | 0.090 |
Why?
|
Prediabetic State | 1 | 2016 | 547 | 0.090 |
Why?
|
Glycemic Index | 2 | 2020 | 400 | 0.080 |
Why?
|
Double-Blind Method | 1 | 2024 | 12430 | 0.080 |
Why?
|
Endpoint Determination | 1 | 2013 | 592 | 0.080 |
Why?
|
Adolescent Behavior | 1 | 2018 | 1184 | 0.080 |
Why?
|
Prisoners | 1 | 1993 | 315 | 0.080 |
Why?
|
Mutagens | 1 | 2010 | 181 | 0.080 |
Why?
|
Disease Progression | 3 | 2016 | 13640 | 0.080 |
Why?
|
Deafness | 1 | 1993 | 460 | 0.080 |
Why?
|
Nutrition Policy | 1 | 2013 | 467 | 0.080 |
Why?
|
Insulin Resistance | 1 | 2022 | 3989 | 0.080 |
Why?
|
Cochlear Implants | 1 | 1993 | 342 | 0.080 |
Why?
|
Micronutrients | 2 | 2021 | 390 | 0.080 |
Why?
|
Research | 1 | 2017 | 1977 | 0.080 |
Why?
|
Thinness | 1 | 2011 | 482 | 0.080 |
Why?
|
Chronic Disease | 2 | 2015 | 9357 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 2 | 2016 | 6512 | 0.080 |
Why?
|
Quinoxalines | 1 | 2010 | 297 | 0.070 |
Why?
|
Molecular Epidemiology | 1 | 2010 | 473 | 0.070 |
Why?
|
Registries | 4 | 2018 | 8351 | 0.070 |
Why?
|
Aged, 80 and over | 10 | 2020 | 59550 | 0.070 |
Why?
|
Case-Control Studies | 4 | 2014 | 22248 | 0.070 |
Why?
|
Health Services Accessibility | 1 | 2005 | 5514 | 0.070 |
Why?
|
Acquired Immunodeficiency Syndrome | 2 | 1996 | 2205 | 0.070 |
Why?
|
Parity | 2 | 2002 | 931 | 0.070 |
Why?
|
Particulate Matter | 1 | 2019 | 2635 | 0.070 |
Why?
|
Food Preferences | 1 | 2010 | 397 | 0.070 |
Why?
|
Neuropsychological Tests | 2 | 2001 | 7119 | 0.070 |
Why?
|
Women's Health | 3 | 2020 | 2081 | 0.070 |
Why?
|
Vitamin B 6 | 2 | 2007 | 237 | 0.060 |
Why?
|
Neoplasm Invasiveness | 4 | 2021 | 3609 | 0.060 |
Why?
|
Vagina | 1 | 1991 | 849 | 0.060 |
Why?
|
Socioeconomic Factors | 3 | 2022 | 7841 | 0.060 |
Why?
|
China | 4 | 2012 | 2383 | 0.060 |
Why?
|
Kaempferols | 1 | 2005 | 22 | 0.060 |
Why?
|
Energy Metabolism | 1 | 2016 | 2903 | 0.060 |
Why?
|
Anxiety | 1 | 2020 | 4670 | 0.060 |
Why?
|
Tumor Burden | 1 | 2011 | 1900 | 0.060 |
Why?
|
Antihypertensive Agents | 1 | 2015 | 2030 | 0.060 |
Why?
|
Depression | 2 | 2020 | 8228 | 0.060 |
Why?
|
Prejudice | 1 | 1989 | 568 | 0.060 |
Why?
|
Diabetes Mellitus | 2 | 2016 | 5887 | 0.060 |
Why?
|
Cholesterol, HDL | 2 | 2001 | 1812 | 0.060 |
Why?
|
Quercetin | 1 | 2005 | 97 | 0.060 |
Why?
|
Hormone Replacement Therapy | 2 | 2014 | 751 | 0.060 |
Why?
|
Survival | 1 | 2005 | 160 | 0.060 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2017 | 3359 | 0.060 |
Why?
|
Receptors, Androgen | 1 | 2011 | 1089 | 0.060 |
Why?
|
Mortality | 2 | 2015 | 2910 | 0.060 |
Why?
|
Vitamin B 12 | 2 | 2007 | 531 | 0.060 |
Why?
|
Marital Status | 2 | 1998 | 426 | 0.060 |
Why?
|
Iowa | 1 | 2004 | 100 | 0.060 |
Why?
|
Imidazoles | 1 | 2010 | 1168 | 0.060 |
Why?
|
New Mexico | 1 | 2004 | 80 | 0.060 |
Why?
|
Melatonin | 1 | 2009 | 670 | 0.060 |
Why?
|
Diet, Mediterranean | 1 | 2011 | 746 | 0.060 |
Why?
|
Triglycerides | 2 | 2001 | 2441 | 0.050 |
Why?
|
Recreation | 1 | 2024 | 124 | 0.050 |
Why?
|
Food Contamination | 1 | 2005 | 193 | 0.050 |
Why?
|
Physical Exertion | 1 | 2006 | 667 | 0.050 |
Why?
|
Research Design | 2 | 2015 | 6207 | 0.050 |
Why?
|
Lymphatic Metastasis | 1 | 2011 | 2901 | 0.050 |
Why?
|
Connecticut | 1 | 2004 | 365 | 0.050 |
Why?
|
Social Isolation | 1 | 2006 | 366 | 0.050 |
Why?
|
Food | 1 | 2007 | 764 | 0.050 |
Why?
|
Diet Records | 2 | 2020 | 425 | 0.050 |
Why?
|
Patient Compliance | 1 | 2013 | 2694 | 0.050 |
Why?
|
Plant Oils | 1 | 2023 | 199 | 0.050 |
Why?
|
Epilepsy, Temporal Lobe | 2 | 2003 | 390 | 0.050 |
Why?
|
Menarche | 1 | 2005 | 532 | 0.050 |
Why?
|
Flavonoids | 1 | 2005 | 447 | 0.050 |
Why?
|
Emigration and Immigration | 1 | 2005 | 405 | 0.050 |
Why?
|
Colorectal Neoplasms | 3 | 2006 | 6962 | 0.050 |
Why?
|
Communicable Diseases | 1 | 2010 | 872 | 0.050 |
Why?
|
Attitude to Health | 1 | 2010 | 2021 | 0.050 |
Why?
|
Statistics, Nonparametric | 1 | 2007 | 2846 | 0.050 |
Why?
|
Age Distribution | 3 | 2015 | 2869 | 0.050 |
Why?
|
Sleep | 1 | 2017 | 4815 | 0.050 |
Why?
|
Hormones | 1 | 2005 | 866 | 0.050 |
Why?
|
Dietary Fats, Unsaturated | 1 | 2002 | 222 | 0.040 |
Why?
|
Weight Loss | 1 | 2012 | 2712 | 0.040 |
Why?
|
Receptor, erbB-2 | 1 | 2011 | 2597 | 0.040 |
Why?
|
Medicare | 1 | 2019 | 6820 | 0.040 |
Why?
|
Bedding and Linens | 1 | 2000 | 41 | 0.040 |
Why?
|
Cost of Illness | 1 | 2010 | 1949 | 0.040 |
Why?
|
Blood Pressure | 1 | 2015 | 8533 | 0.040 |
Why?
|
Homocysteine | 1 | 2003 | 638 | 0.040 |
Why?
|
Melanoma | 1 | 2018 | 5700 | 0.040 |
Why?
|
Electricity | 1 | 2000 | 173 | 0.040 |
Why?
|
Estrogen Replacement Therapy | 1 | 2006 | 1205 | 0.040 |
Why?
|
Calcium, Dietary | 1 | 2002 | 527 | 0.040 |
Why?
|
Central Nervous System Stimulants | 1 | 2008 | 1168 | 0.040 |
Why?
|
Self Efficacy | 1 | 2004 | 643 | 0.040 |
Why?
|
Neuroendocrine Tumors | 1 | 2005 | 659 | 0.040 |
Why?
|
Seizures | 2 | 2003 | 2996 | 0.040 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2006 | 934 | 0.040 |
Why?
|
Breast Diseases | 1 | 2002 | 441 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2018 | 5861 | 0.040 |
Why?
|
Arm | 1 | 2021 | 591 | 0.040 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2022 | 904 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 3250 | 0.040 |
Why?
|
Intelligence Tests | 1 | 1998 | 504 | 0.040 |
Why?
|
Animals | 6 | 2009 | 168930 | 0.040 |
Why?
|
Insurance, Health | 2 | 2005 | 2520 | 0.040 |
Why?
|
Epilepsy | 2 | 2004 | 3317 | 0.030 |
Why?
|
Age Factors | 2 | 2005 | 18397 | 0.030 |
Why?
|
Reproducibility of Results | 5 | 2007 | 20144 | 0.030 |
Why?
|
Clinical Trials as Topic | 2 | 2020 | 8045 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2022 | 1117 | 0.030 |
Why?
|
Coronary Disease | 2 | 2001 | 5915 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2007 | 14652 | 0.030 |
Why?
|
Tobacco Smoke Pollution | 1 | 2002 | 828 | 0.030 |
Why?
|
Cerebral Cortex | 2 | 2004 | 5753 | 0.030 |
Why?
|
Fatty Acids | 2 | 2005 | 1806 | 0.030 |
Why?
|
Fatty Acids, Unsaturated | 1 | 1999 | 539 | 0.030 |
Why?
|
Steroids | 1 | 2000 | 936 | 0.030 |
Why?
|
Prehypertension | 1 | 2015 | 63 | 0.030 |
Why?
|
Sex Distribution | 2 | 2015 | 2274 | 0.030 |
Why?
|
Malnutrition | 1 | 2021 | 629 | 0.030 |
Why?
|
Television | 1 | 1998 | 409 | 0.030 |
Why?
|
Adipose Tissue | 1 | 2007 | 3314 | 0.030 |
Why?
|
Adenoma | 1 | 2005 | 2155 | 0.030 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2007 | 2160 | 0.030 |
Why?
|
Risk Reduction Behavior | 1 | 2021 | 1120 | 0.030 |
Why?
|
Rural Health | 1 | 2016 | 302 | 0.030 |
Why?
|
Meta-Analysis as Topic | 1 | 1999 | 1365 | 0.030 |
Why?
|
Genomics | 1 | 2010 | 5923 | 0.030 |
Why?
|
Insurance Claim Review | 1 | 2019 | 744 | 0.030 |
Why?
|
Prostate-Specific Antigen | 1 | 2004 | 2463 | 0.030 |
Why?
|
Sign Language | 1 | 1993 | 12 | 0.030 |
Why?
|
Urban Health | 1 | 2016 | 532 | 0.030 |
Why?
|
Interviews as Topic | 2 | 2009 | 2741 | 0.030 |
Why?
|
SEER Program | 1 | 2019 | 1443 | 0.030 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2007 | 3246 | 0.020 |
Why?
|
Leukorrhea | 1 | 1991 | 4 | 0.020 |
Why?
|
Arthritis, Rheumatoid | 1 | 2007 | 3788 | 0.020 |
Why?
|
Vaginitis | 1 | 1991 | 50 | 0.020 |
Why?
|
Hygiene | 1 | 1991 | 95 | 0.020 |
Why?
|
Child | 4 | 2008 | 80668 | 0.020 |
Why?
|
Health Status | 2 | 2002 | 4087 | 0.020 |
Why?
|
Condoms | 1 | 1993 | 336 | 0.020 |
Why?
|
Propensity Score | 1 | 2019 | 1972 | 0.020 |
Why?
|
Brain Diseases | 1 | 2000 | 1552 | 0.020 |
Why?
|
New York City | 1 | 1993 | 736 | 0.020 |
Why?
|
Therapeutic Irrigation | 1 | 1991 | 297 | 0.020 |
Why?
|
Risk-Taking | 1 | 1996 | 1021 | 0.020 |
Why?
|
Vaginal Smears | 1 | 1993 | 505 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2005 | 12985 | 0.020 |
Why?
|
Wisconsin | 1 | 2009 | 122 | 0.020 |
Why?
|
New Hampshire | 1 | 2009 | 174 | 0.020 |
Why?
|
Taste | 1 | 2010 | 190 | 0.020 |
Why?
|
Health Education | 1 | 1996 | 1060 | 0.020 |
Why?
|
Education | 1 | 1991 | 531 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2000 | 10745 | 0.020 |
Why?
|
Pteroylpolyglutamic Acids | 1 | 2007 | 9 | 0.020 |
Why?
|
Teaching | 1 | 2015 | 1171 | 0.020 |
Why?
|
Africa | 1 | 2010 | 726 | 0.020 |
Why?
|
Tryptophan | 1 | 2009 | 484 | 0.020 |
Why?
|
Organizational Innovation | 1 | 2010 | 540 | 0.020 |
Why?
|
Breast Feeding | 1 | 1995 | 1363 | 0.020 |
Why?
|
Radioimmunoassay | 1 | 2007 | 861 | 0.020 |
Why?
|
Predictive Value of Tests | 3 | 2012 | 15416 | 0.020 |
Why?
|
Insulin | 1 | 2020 | 6608 | 0.020 |
Why?
|
Blood Glucose | 1 | 2020 | 6422 | 0.020 |
Why?
|
Tocopherols | 1 | 2005 | 43 | 0.020 |
Why?
|
Awareness | 1 | 2010 | 653 | 0.020 |
Why?
|
Health Care Costs | 1 | 2019 | 3242 | 0.020 |
Why?
|
Functional Laterality | 2 | 2003 | 2243 | 0.020 |
Why?
|
Methionine | 1 | 2007 | 569 | 0.020 |
Why?
|
Aging | 1 | 2004 | 8731 | 0.020 |
Why?
|
Somatomedins | 1 | 2005 | 179 | 0.020 |
Why?
|
Fasting | 2 | 2001 | 1609 | 0.020 |
Why?
|
Age of Onset | 2 | 2003 | 3342 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 3230 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1993 | 6214 | 0.010 |
Why?
|
Population Surveillance | 1 | 2015 | 2594 | 0.010 |
Why?
|
Community Networks | 1 | 2006 | 202 | 0.010 |
Why?
|
Mathematical Computing | 1 | 2004 | 142 | 0.010 |
Why?
|
Focus Groups | 1 | 2010 | 1459 | 0.010 |
Why?
|
Comorbidity | 2 | 2001 | 10580 | 0.010 |
Why?
|
Metabolic Networks and Pathways | 1 | 2007 | 800 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2007 | 13485 | 0.010 |
Why?
|
Epidemiologic Methods | 1 | 2007 | 1326 | 0.010 |
Why?
|
Inflammation | 1 | 2022 | 10860 | 0.010 |
Why?
|
Health Status Indicators | 1 | 2006 | 968 | 0.010 |
Why?
|
Hysterectomy | 1 | 2006 | 863 | 0.010 |
Why?
|
Obesity, Morbid | 1 | 2011 | 1292 | 0.010 |
Why?
|
Mental Health | 1 | 2015 | 3270 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2012 | 8540 | 0.010 |
Why?
|
Electrodes | 1 | 2003 | 610 | 0.010 |
Why?
|
Recurrence | 1 | 2013 | 8507 | 0.010 |
Why?
|
Retrospective Studies | 3 | 2005 | 81635 | 0.010 |
Why?
|
Seizures, Febrile | 1 | 2001 | 109 | 0.010 |
Why?
|
Videotape Recording | 1 | 2001 | 333 | 0.010 |
Why?
|
Medical History Taking | 1 | 2003 | 779 | 0.010 |
Why?
|
Neurologic Examination | 1 | 2001 | 913 | 0.010 |
Why?
|
Colonoscopy | 1 | 2005 | 1409 | 0.010 |
Why?
|
Databases, Factual | 1 | 2012 | 8066 | 0.010 |
Why?
|
Boston | 3 | 1996 | 9346 | 0.010 |
Why?
|
Child, Preschool | 2 | 2003 | 42577 | 0.010 |
Why?
|
Models, Biological | 1 | 2012 | 9461 | 0.010 |
Why?
|
Electrodes, Implanted | 1 | 2000 | 835 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2011 | 15908 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2001 | 1794 | 0.010 |
Why?
|
Family | 1 | 2001 | 3209 | 0.010 |
Why?
|
Models, Statistical | 1 | 2004 | 5091 | 0.010 |
Why?
|
Health Personnel | 1 | 2002 | 3384 | 0.000 |
Why?
|
Uterine Hemorrhage | 1 | 1989 | 235 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2012 | 65273 | 0.000 |
Why?
|
Gonorrhea | 1 | 1989 | 355 | 0.000 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2000 | 8926 | 0.000 |
Why?
|
Infant, Newborn | 1 | 2003 | 26389 | 0.000 |
Why?
|
Infant | 1 | 2003 | 36461 | 0.000 |
Why?
|
Models, Theoretical | 1 | 1989 | 3561 | 0.000 |
Why?
|
Brain | 1 | 2003 | 27159 | 0.000 |
Why?
|